Literature DB >> 8006457

Protective effect of N-acetylcysteine in hapten-induced irritant and contact hypersensitivity reactions.

G Senaldi1, P Pointaire, P F Piguet, G E Grau.   

Abstract

The hapten-induced irritant and contact hypersensitivity reactions are experimental models of cutaneous inflammation in which tumor necrosis factor-alpha is an important mediator. N-acetylcysteine is an anti-oxidant that inhibits the action of the nuclear factor-kB, which promotes the transcription of many genes, including the gene for tumor necrosis factor-alpha. We tested the ability of N-acetylcysteine to antagonize the development of the irritant and contact hypersensitivity reactions induced by the epicutaneous application of trinitrochlorobenzene in mice. Systemic and topical treatment with N-acetylcysteine reduced skin swelling in both the irritant and contact hypersensitivity reactions; in the latter it also reduced the dermal leukocyte infiltrate. It also reduced the cutaneous expression of the mRNA for tumor necrosis factor-alpha in both conditions. These results show that N-acetylcysteine antagonizes the development of irritant and contact hypersensitivity reactions and that its action includes a reduction in the expression of tumor necrosis factor-alpha mRNA. N-acetylcysteine may be useful in the treatment of cutaneous inflammation mediated by tumor necrosis factor-alpha.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006457     DOI: 10.1111/1523-1747.ep12384093

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  Regulation of ICAM-1 expression in mouse macrophages.

Authors:  A K Hubbard; C Giardina
Journal:  Inflammation       Date:  2000-04       Impact factor: 4.092

2.  Suppressive effect of administration of recombinant human thioredoxin on cutaneous  inflammation caused by UV.

Authors:  Ryusuke Ono; Atsushi Fukunaga; Taro Masaki; Xijun Yu; Junji Yodoi; Chikako Nishigori
Journal:  Bioengineered       Date:  2013-01-17       Impact factor: 3.269

Review 3.  Redox imbalance in T cell-mediated skin diseases.

Authors:  Saveria Pastore; Liudmila Korkina
Journal:  Mediators Inflamm       Date:  2010-08-04       Impact factor: 4.711

4.  Thioredoxin ameliorates cutaneous inflammation by regulating the epithelial production and release of pro-inflammatory cytokines.

Authors:  Hai Tian; Yoshiyuki Matsuo; Atsushi Fukunaga; Ryusuke Ono; Chikako Nishigori; Junji Yodoi
Journal:  Front Immunol       Date:  2013-09-09       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.